Details for New Drug Application (NDA): 011635
✉ Email this page to a colleague
NDA 011635 describes DIUPRES-500, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the DIUPRES-500 profile page.
The generic ingredient in DIUPRES-500 is chlorothiazide; reserpine. There are forty-two drug master file entries for this compound. Additional details are available on the chlorothiazide; reserpine profile page.
The generic ingredient in DIUPRES-500 is chlorothiazide; reserpine. There are forty-two drug master file entries for this compound. Additional details are available on the chlorothiazide; reserpine profile page.
Summary for 011635
| Tradename: | DIUPRES-500 |
| Applicant: | Merck |
| Ingredient: | chlorothiazide; reserpine |
| Patents: | 0 |
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG;0.125MG | ||||
| Approval Date: | Aug 26, 1987 | TE: | RLD: | No | |||||
Profile for product number 006
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG;0.125MG | ||||
| Approval Date: | Aug 26, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
